Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Model

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|February 15, 2023
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Martin S Weber, et al.
Clinical Chemistry|December 20, 2007
DNA methylation biomarkers for blood-based colorectal cancer screeningCatherine Lofton-Day, Fabian Model, Theo Devos, et al.
The Prostate|May 22, 2009
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detectionShannon R Payne, Jurgen Serth, Martin Schostak, et al.
Gastroenterology|November 15, 2006
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomasMatthias P A Ebert, Fabian Model, Suzanne Mooney, et al.
Clinical Chemistry|May 2, 2009
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancerTheo deVos, Reimo Tetzner, Fabian Model, et al.
Molecular Genetics and Metabolism|February 25, 2026
Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidosesCandice B Herber, Shaohua Xiao, Deborah S Gho, et al.
Neurology|July 22, 2020
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extensionStephen L Hauser, Ludwig Kappos, Douglas L Arnold, et al.
Cancer Research|January 17, 2009
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissueGeorg Wieczorek, Anne Asemissen, Fabian Model, et al.
Ebiomedicine|June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsAmit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Molecular Cancer Research : MCR|February 23, 2007
Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of diseaseFabian Model, Neal Osborn, David Ahlquist, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neurology(R) Neuroimmunology & Neuroinflammation|February 15, 2023
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Martin S Weber, et al.
Clinical Chemistry|December 20, 2007
DNA methylation biomarkers for blood-based colorectal cancer screeningCatherine Lofton-Day, Fabian Model, Theo Devos, et al.
The Prostate|May 22, 2009
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detectionShannon R Payne, Jurgen Serth, Martin Schostak, et al.
Gastroenterology|November 15, 2006
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomasMatthias P A Ebert, Fabian Model, Suzanne Mooney, et al.
Clinical Chemistry|May 2, 2009
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancerTheo deVos, Reimo Tetzner, Fabian Model, et al.
Molecular Genetics and Metabolism|February 25, 2026
Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidosesCandice B Herber, Shaohua Xiao, Deborah S Gho, et al.
Neurology|July 22, 2020
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extensionStephen L Hauser, Ludwig Kappos, Douglas L Arnold, et al.
Cancer Research|January 17, 2009
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissueGeorg Wieczorek, Anne Asemissen, Fabian Model, et al.
Ebiomedicine|June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsAmit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Molecular Cancer Research : MCR|February 23, 2007
Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of diseaseFabian Model, Neal Osborn, David Ahlquist, et al.
Pageof 3